-+ 0.00%
-+ 0.00%
-+ 0.00%
DuPont (DD) Stock May Be 29% Undervalued Despite Raised Guidance
Share
Listen to the news

DuPont de Nemours has delivered a strong share price run in recent years, and the question now is whether the cash the business generates can fully support where the stock trades today. With the market reacting to fresh company updates, investors are weighing how much of that cash flow story is already embedded in the current valuation.

  • Over the past 3 years the stock has returned 88.3%, which puts a lot of weight on the assumption that future cash flows can keep backing up that kind of move.
  • Recent company updates highlight growth in key end markets and better productivity, which can support expectations for stronger margins and potentially steadier cash generation over time.
  • If you'd rather focus on earnings, this one's for you. See why DuPont de Nemours's 53.6x P/E tells a different valuation story.

The issue now is whether DuPont de Nemours' current share price of US$156.88 is justified by the intrinsic value suggested by its cash flows.

If you want a clear comparison point for DuPont de Nemours' cash flow story, line it up against 35 high quality undervalued stocks.

Is DuPont de Nemours a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model here focuses on the cash DuPont de Nemours can return to shareholders over time. Latest twelve month free cash flow sits at about $568.3 million, and the projections assume this moves onto a growing track rather than a shrinking one, with expected free cash flow stepping up over the next decade.

DCF outputs suggest that, based on these cash flow estimates, the stock carries an estimated intrinsic value that is meaningfully above the current share price of $156.88. Because DuPont reported stronger Q3 2026 trading and lifted full year guidance while also planning a $250 million buyback, the market reaction still leaves the shares priced below what the model implies the cash flows are worth. Find out what DuPont de Nemours could be worth using our Discounted Cash Flow (DCF) estimate.

The DuPont de Nemours Narrative: What Would Justify Today's Price?

Narratives for DuPont de Nemours pick up where that valuation puzzle leaves off by spelling out which future paths for growth, profitability and earnings would need to play out for the stock to be worth materially more or materially less than today, and they sit on Simply Wall St's Community page. Instead of stopping at a single output from a ratio or model, these narratives describe the future assumptions behind that figure so you can track how actual results compare with those expectations over time.

Views on DuPont de Nemours are now split between analysts who see more upside in the refocused portfolio and those who think expectations already run hot.

Bull case: 9% undervalued

This view comes from the analyst consensus Narrative on Simply Wall St. It rolls up mainstream forecasts into a single storyline.

"R&D spending of about 2.5% of sales, a vitality index around 35%, and the use of AI tools in labs and commercial work, including the Uncountable collaboration and AI ready labs, support faster product cycles in areas like healthcare, water and EVs…"

Discover why this Narrative puts DuPont de Nemours at 9% undervalued.

Bear case: roughly fairly valued

The more cautious angle is set out in the bearish analyst Narrative on Simply Wall St. It leans on the lowest published targets.

"Despite consistently high free cash flow conversion and sizeable share repurchases alongside more than US$1b of M&A capacity, the approximately US$126 million PFAS related settlement payable over 15 years represents a recurring cash drain…"

Explore why this Narrative puts DuPont de Nemours at roughly fairly valued.

One more angle on DuPont de Nemours that could change how you see it

Valuation only tells part of the story for DuPont de Nemours, because the research checks have also flagged specific areas of concern that deserve your attention before you lean on any single model. Take a closer look at 2 warning signs before settling on a valuation.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending